Buy Apellis Pharma Stock | APLS Stock Price & Latest News | Public.com
APLS

Apellis Pharma

$0.00 (0.00%)Today
    View Apellis Pharma (APLS) stock trends here

    About APLS

    Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which develops novel therapeutic compounds. It develops complement immunotherapies for the treatment of complement-dependent autoimmune and inflammatory diseases through APL-2 product. The comp...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0.93
    0.02
    -0.89
    -1.79
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$1.63

    Actual EPS
    Q1 2021

    Stats

    Market Cap$3,66B
    Volume292,2k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$58.47
    1 Year Low$16.85
    Open$45.63
    High$46.28
    Low$44.85

    Buy any stock with any amount of money.

    Download the App
    Download the app